Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07817043

Microbiology Operations & Time Optimization in Sepsis

The goal of this study is to simulate turn-around times of blood cultures from blood culture collection to final communication of the result. The main objective is to develop a web-based tool that is able to simulate heterogeneous laboratory settings and to analyse the impact of infrastructure and opening hours on blood culture turn-around times.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

About this study

will follow

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

microbiological laboratories conducting blood culture analysis

Treatment and study plan

laboratory infrastructure

Diagnostic Test

will follow

Primary outcomes

  1. Turn-around time

    Time frame: 4 weeks for the conduction of the simulation

Study contacts

Contact information is provided by the study sponsor or research team.

Christian S Scheer, MD

CONTACT

[email protected]

Evgeny A Idelevich, MD, Prof.

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University Medicine Greifswald

Other

Collaborators

  • Karolinska University Hospital

Registry information

Official study title

A Simulation Platform for Optimising Blood Culture Diagnostics in Sepsis

Acronym: MOTION-Sepsis

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Sep 14, 2026
Registry last updated
Sep 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.